Upneeq

Upneeq is the FIRST AND ONLY, FDA-approved, non-invasive treatment to improve low-lying lids by contracting the Mueller’s Muscle. Upneeq is used to treat acquired blepharoptosis in adults.

  • First In-Class Treatment
  • Active Ingredient Oxymetazoline Hydrochloride. 1%
  • Delivers rapid, visible lift to the upper eyelid with once-daily use
  • 1mm-3mm average lift of upper eyelid
  • Achieved significant visual field improvement
  • Some patients may start to observe efficiency 5-15 minutes post-dose, Lasting effect up to 8 hours post-dose
  • 0 Contraindications

See The Difference

UPQBA3 2hour
UPQBA1 1hour
UPQBA1 30min
UPQBA1 15min
UPQBA1 2hour
UPQBA2 2hour

Contact Us

  • * All indicated fields must be completed.
    Please include non-medical questions and correspondence only.
  • This field is for validation purposes and should be left unchanged.

Stay In Touch!

Subscribe To Our Email For News, Info And Specials.

By subscribing to our email you agree to our
terms of service and privacy policy.
By subscribing to our email you agree to our terms of service and privacy policy.

Scroll to Top